Sfoglia per RIVISTA
FRONTIERS IN IMMUNOLOGY
Collezione AO Cuneo
Items : 6
V?9V?2 T-cell immunotherapy in blood cancers: ready for prime time? in Frontiers in immunology / Front Immunol. 2023 Apr 18;14:1167443. doi: 10.3389/fimmu.2023.1167443. eCollection 2023.
2023
AO Cuneo
Giannotta C; Autino F; Massaia M;
Immune dysfunctions affecting bone marrow V?9V?2 T cells in multiple myeloma: Role of immune checkpoints and disease status. in Frontiers in immunology / Front Immunol. 2022 Dec 20;13:1073227. doi: 10.3389/fimmu.2022.1073227. eCollection 2022.
2022
AOU Città della Salute di Torino
AO Cuneo
Avonto I; Massaia M; Riganti C; Grasso M; Kopecka J; D'Agostino M; Larocca A; Tripoli E; Grimaldi D; Castella B; Giannotta C;
The immune suppressive tumor microenvironment in multiple myeloma: The contribution of myeloid-derived suppressor cells. in Frontiers in immunology / Front Immunol. 2023 Jan 16;13:1102471. doi: 10.3389/fimmu.2022.1102471. eCollection 2022.
2022
AO Cuneo
Massaia M; Giannotta C; Autino F;
V?9V?2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression. in Frontiers in immunology / Front Immunol. 2018 Jun 25;9:1492. doi: 10.3389/fimmu.2018.01492. eCollection 2018.
2018
AO Cuneo
Massaia M; Riganti C; Foglietta M; Castella B;
ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells. in Frontiers in immunology / Front Immunol. 2018 Jun 8;9:1246. doi: 10.3389/fimmu.2018.01246. eCollection 2018.
2018
AO Cuneo
Riganti C; Castella B; Massaia M;
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. in Frontiers in immunology / Front Immunol. 2017 Mar 23;8:321. doi: 10.3389/fimmu.2017.00321. eCollection 2017.
2017
AOU San Luigi di Orbassano
AO Cuneo
AOU Novara
Chiocchetti A; Dianzani U; Leone M; Sblattero D; Cena T; Ambrogio L; Martinelli-Boneschi F; Caldano M; Bertolotto A; Dianzani C; Sorosina M; Boggio E; Orilieri E; Gigliotti CL; Vecchio D; Cappellano G; Raineri D; Comi C; Clemente N;